A Post‐Hoc Comparison of the Utility of Sanger Sequencing and Exome Sequencing for the Diagnosis of Heterogeneous Diseases
暂无分享,去创建一个
Christian Gilissen | Ilse Feenstra | Nienke Wieskamp | Kornelia Neveling | Hans Scheffer | J. Veltman | M. Nelen | H. Brunner | H. Kremer | F. Cremers | L. Hoefsloot | R. Rodenburg | B. P. Warrenburg | C. Gilissen | M. Ligtenberg | T. Rinne | H. Scheffer | Nienke Wieskamp | S. Wortmann | I. Feenstra | J. Smeitink | S. Vermeer | K. Neveling | E. Kamsteeg | D. Lugtenberg | H. Yntema | C. Marcelis | D. Koolen | A. Mensenkamp | Hannie Kremer | L. Spruijt | R. Reuver | Sascha Vermeer | Tuula Rinne | Liesbeth Spruijt | David A. Koolen | Han G. Brunner | Joris A. Veltman | Marcel R. Nelen | Dorien Lugtenberg | Danielle Bodmer | K. Gassen | D. Bodmer | Wendy Buijsman | R. Derks | B. Heuvel | W. A. Zelst-Stams | Lies H. Hoefsloot | Erik‐Jan Kamsteeg | Arjen R. Mensenkamp | Richard J. T. Rodenburg | Helger G. Yntema | Koen L. Gassen | Rick Reuver | Wendy Buijsman | Ronny C. Derks | Bert Heuvel | Marjolijn J.L. Ligtenberg | Bart P.C. Warrenburg | Frans P.M. Cremers | Carlo L.M. Marcelis | Jan A.M. Smeitink | Saskia B. Wortmann | Wendy A.G. Zelst‐Stams | B. Warrenburg | W. V. Zelst-Stams | W. A. Zelst-Stams
[1] Steven Henikoff,et al. SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..
[2] Christian Gilissen,et al. De novo mutations of SETBP1 cause Schinzel-Giedion syndrome , 2010, Nature Genetics.
[3] Thomas L. Casavant,et al. First Exons and Introns - A Survey of GC Content and Gene Structure in the Human Genome , 2006, Silico Biol..
[4] Christian Gilissen,et al. Unlocking Mendelian disease using exome sequencing , 2011, Genome Biology.
[5] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[6] B. V. van Bon,et al. Diagnostic exome sequencing in persons with severe intellectual disability. , 2012, The New England journal of medicine.
[7] Vineet Bafna,et al. Exome Sequencing Can Improve Diagnosis and Alter Patient Management , 2012, Science Translational Medicine.
[8] Juliane C. Dohm,et al. Substantial biases in ultra-short read data sets from high-throughput DNA sequencing , 2008, Nucleic acids research.
[9] Shunsuke Kato,et al. Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods , 2006, Nucleic acids research.
[10] K. Pollard,et al. Detection of nonneutral substitution rates on mammalian phylogenies. , 2010, Genome research.
[11] H. Brunner,et al. Is early‐onset microsatellite and chromosomally stable colorectal cancer a hallmark of a genetic susceptibility syndrome? , 2008, International journal of cancer.
[12] John Broxholme,et al. Next-generation sequencing (NGS) as a diagnostic tool for retinal degeneration reveals a much higher detection rate in early-onset disease , 2012, European Journal of Human Genetics.
[13] Emily H Turner,et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome , 2010, Nature Genetics.
[14] J. Schuurs-Hoeijmakers,et al. Mutations in the phospholipid remodeling gene SERAC1 impair mitochondrial function and intracellular cholesterol trafficking and cause dystonia and deafness , 2012, Nature Genetics.
[15] Kelly Schoch,et al. Clinical application of exome sequencing in undiagnosed genetic conditions , 2012, Journal of Medical Genetics.
[16] Quinten Waisfisz,et al. Best Practice Guidelines for the Use of Next‐Generation Sequencing Applications in Genome Diagnostics: A National Collaborative Study of Dutch Genome Diagnostic Laboratories , 2013, Human mutation.
[17] Christian Gilissen,et al. Next-generation genetic testing for retinitis pigmentosa , 2012, Human mutation.
[18] J. Shendure,et al. Exome sequencing as a tool for Mendelian disease gene discovery , 2011, Nature Reviews Genetics.
[19] Heikki Joensuu,et al. Comparison of solution-based exome capture methods for next generation sequencing , 2011, Genome Biology.
[20] B. J. Klevering,et al. Outcome of ABCA4 microarray screening in routine clinical practice , 2009, Molecular vision.
[21] Muin J Khoury,et al. Deploying whole genome sequencing in clinical practice and public health: Meeting the challenge one bin at a time , 2011, Genetics in Medicine.
[22] Christian Gilissen,et al. Massively parallel sequencing of ataxia genes after array‐based enrichment , 2010, Human mutation.
[23] A. Zharkikh,et al. Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral , 2005, Journal of Medical Genetics.
[24] L. Vreede,et al. Germline mutations in the spindle assembly checkpoint genes BUB1 and BUB3 are risk factors for colorectal cancer. , 2013, Gastroenterology.
[25] Hugo Y. K. Lam,et al. Performance comparison of exome DNA sequencing technologies , 2011, Nature Biotechnology.
[26] Christian Gilissen,et al. Disease gene identification strategies for exome sequencing , 2012, European Journal of Human Genetics.
[27] T. Hirose,et al. Mutations in ABCR (ABCA4) in patients with Stargardt macular degeneration or cone-rod degeneration. , 2001, Investigative ophthalmology & visual science.
[28] Peter Donnelly,et al. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas , 2013, Nature Genetics.